sing radioactive iodide 125 in uveal melanoma
Phase 2
- Conditions
- veal melanoma.Choroid
- Registration Number
- IRCT2016091929875N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
INCLUSION: All the patients with uveal melanoma that are not the candidates for ruthenium plaques and un-acception of the enucleation by the patient.
Exclusion: Unwillingness of the patient for continuing the study, pregnancy and nursing.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in the thickness of tumor. Timepoint: At 4 months. Method of measurement: ultrasound and clinical examination.
- Secondary Outcome Measures
Name Time Method